AB I Lamberg can provide expert advice in leadership and project management at various levels. Advice in influencing skills such as various communication techniques and cross functional work can also be provided.
AB I Lamberg can provide Regulatory strategic input at various levels.
AB I Lamberg can provide hands on work in compiling various applications.
AB I Lamberg has been working with companies giving leadership advices to move the business forward.
Ingrid Lamberg, the founder and owner of AB I Lamberg Consulting, is an experienced Leader and Regulatory Affairs Professional with almost 25 years in the pharmaceutical industry and AstraZeneca R&D.
Ingrid Lamberg was initially working as Regulatory Affairs Manager at Astra, primarily with Chemistry Manufacturing and Control, CMC. The work evolved to include more aspects of regulatory affairs as well as project leadership. At the time of the merger, Astra to AstraZeneca, Ingrid Lamberg got a position as Global Regulatory Lead and Regulatory Affairs Director. The main responsibility was to lead the regulatory work in giving strategic advice and leadership.
The work was mainly focusing in late stage but also early phase development both for respiratory and gastro intestinal therapeutic areas. The respiratory portfolio consisted of inhalation products, tablets and medical devices.
The strategic input was an important factor in gaining a successful outcome. The work resulted in a substantial amount of applications such as MAAs, CTAs, NDAs, sNDA and JNDAs.
As global responsible for regulatory affairs projects/portfolios, Ingrid Lamberg has taken part in several agency consultations in USA, EU and Japan. In addition Ingrid Lamberg has contributed to regulatory expertise in liaison.
Ingrid Lamberg has a Master of Science in Chemical Engineering, and a PhD in Food Engineering, Faculty of Engineering at Lund University Sweden and has also been working as a scientist at Food Engineering, Faculty of Engineering at Lund University, Sweden.